PATRICK GRADY: Open Payments
NPI 1578702569 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 38 payments from 15 companies in 2025. Trend: 2023 $1,186 · 2024 $1,307 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $228 |
| PFIZER INC. | 5 | $129 |
| ABBVIE INC. | 4 | $94 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Amgen Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Novo Nordisk Inc | 2 | $54 |
| Hologic Sales and Service, LLC | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Lilly USA, LLC | 2 | $43 |
Products named: AIRSUPRA, NURTEC ODT, NEXIUM, SHINGRIX, Wegovy, XIFAXAN, QULIPTA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.
Industry payments across CO — which companies pay providers there.
